Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Linde
LIN
|
+$1.32B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$515M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 4 |
Williams Companies
WMB
|
+$274M |
| 5 |
Healthpeak Properties
DOC
|
+$257M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Apple
AAPL
|
+$884M |
| 3 |
Microsoft
MSFT
|
+$880M |
| 4 |
Intel
INTC
|
+$717M |
| 5 |
Johnson & Johnson
JNJ
|
+$705M |
Sector Composition
| 1 | Technology | 12.93% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 12.37% |
| 4 | Industrials | 8.2% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Byline Bancorp
BY
$1.32B
| $356K | ﹤0.01% |
21,550
-15,678
| -42% | -$259K |
|
3352
OneMain Financial
OMF
$7.3B
| $356K | ﹤0.01% |
14,770
-214,332
| -94% | -$5.17M |
|
3353
America Movil
AMX
$61.7B
| $355K | ﹤0.01% |
25,005
-135,884
| -84% | -$1.93M |
|
|
SPNE
3354
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $354K | ﹤0.01% |
19,508
-19,989
| -51% | -$363K |
|
3355
Carriage Services
CSV
$670M
| $353K | ﹤0.01% |
22,892
-17,589
| -43% | -$271K |
|
3356
OrthoPediatrics
KIDS
$490M
| $353K | ﹤0.01% |
10,171
-5,635
| -36% | -$196K |
|
|
ENZ
3357
DELISTED
Enzo Biochem, Inc.
ENZ
| $352K | ﹤0.01% |
126,813
-85,267
| -40% | -$237K |
|
|
FSB
3358
DELISTED
Franklin Financial Network, Inc.
FSB
| $352K | ﹤0.01% |
13,415
-23,964
| -64% | -$629K |
|
|
YELL
3359
DELISTED
Yellow Corporation Common Stock
YELL
| $351K | ﹤0.01% |
112,045
+280
| +0.3% | +$877 |
|
|
BSCK
3360
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
| $350K | ﹤0.01% |
16,634
+16,367
| +6,130% | +$344K |
|
3361
Fidelity MSCI Health Care Index ETF
FHLC
$2.44B
| $349K | ﹤0.01% |
8,451
+6,439
| +320% | +$266K |
|
3362
Minerva Neurosciences
NERV
$15.7M
| $349K | ﹤0.01% |
6,488
-2,901
| -31% | -$156K |
|
|
TEUM
3363
DELISTED
Pareteum Corporation
TEUM
| $349K | ﹤0.01% |
207,000
+201,800
| +3,881% | +$340K |
|
3364
Corbus Pharmaceuticals
CRBP
$115M
| $348K | ﹤0.01% |
1,990
-2,995
| -60% | -$524K |
|
3365
Daily Journal
DJCO
$614M
| $348K | ﹤0.01% |
1,496
-1,089
| -42% | -$253K |
|
|
PFIE
3366
DELISTED
Profire Energy, Inc
PFIE
| $348K | ﹤0.01% |
240,586
+185,910
| +340% | +$269K |
|
|
ATTO
3367
DELISTED
Atento S.A.
ATTO
| $347K | ﹤0.01% |
17,219
-124,674
| -88% | -$2.51M |
|
|
RDGT
3368
Ridgetech, Inc. Ordinary Shares
RDGT
$7.9M
| $346K | ﹤0.01% |
721
+292
| +68% | +$140K |
|
3369
Peoples Bancorp of North Carolina
PEBK
$168M
| $345K | ﹤0.01% |
14,207
-8,471
| -37% | -$206K |
|
|
FRBK
3370
DELISTED
Republic First Bancorp Inc
FRBK
| $345K | ﹤0.01% |
58,167
-104,432
| -64% | -$619K |
|
3371
Harvard Bioscience
HBIO
$19.6M
| $344K | ﹤0.01% |
109,020
-15,268
| -12% | -$48.2K |
|
|
BSJJ
3372
DELISTED
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
| $344K | ﹤0.01% |
14,567
+14,406
| +8,948% | +$340K |
|
3373
Apellis Pharmaceuticals
APLS
$3.08B
| $343K | ﹤0.01% |
26,085
-98,833
| -79% | -$1.3M |
|
3374
Fate Therapeutics
FATE
$110M
| $343K | ﹤0.01% |
26,881
-183,691
| -87% | -$2.34M |
|
3375
Lineage Cell Therapeutics
LCTX
$308M
| $343K | ﹤0.01% |
376,850
+105,022
| +39% | +$95.6K |
|